Ireland
--:--IST
Latest
Clinical Trials in Taiwan / NCT06715995
Recruiting Not applicable

Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults

NCT06715995 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2024-12-09
Last updated
2024-12-04

Condition(s) studied

EEG Brain OscillationsAlzheimer's Disease (AD)Cognitively Normal Older Adults

Investigational drug(s) / intervention(s)

Gamma Wave Stimulation Table Lamp (Aleddra, Inc., USA)

Gamma Wave Stimulation Table Lamp (Aleddra, Inc., USA): Participants will receive light stimulation using the Gamma Wave Stimulation Table Lamp (Aleddra, Inc., USA) for 1 hour per day, 7 days a week, over 4 weeks, for a total of 28 hours.

Study summary

This study aims to evaluate the effects of endogenous gamma non-flickering light stimulation on resting-state EEG rhythms and cognitive function in cognitively healthy older adults. Specifically, it will assess the immediate and long-term effects of this stimulation on brainwave activity and cognitive performance. The study will explore the potential of gamma light stimulation as a non-pharmacological intervention for cognitive decline in aging populations.

Eligibility

Sex
ALL
Min age
55 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * 1\. Age over 55 years old. * 2\. The Cognitive Abilities Screening Instrument (CASI) score is within normal ranges adjusted for age and education. * 3\. Participants have no history of severe neurological or psychiatric disorders (such as stroke, epilepsy, depression, migraine, etc.) that could affect cognitive function. * 4\. Participants have not used drugs that may affect cognitive function (e.g., benzodiazepines, anticholinergic medications, etc.). * 5\. Participants with normal or corrected vision (e.g., glasses or contact lenses) to normal levels. * 6\. Voluntary to sign the Informed Consent Form. Exclusion Criteria: * 1\. Participants enrolled in any cognitive enhancement study within the past two months. * 2\. Participants with a history of disease that could affect cognitive function (e.g., cancer, autoimmune diseases, etc.). * 3\. Pregnant, or planning to become pregnant.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chang Gung University Taoyuan Guishan Recruiting

More Chang Gung Memorial Hospital trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06715995 on ClinicalTrials.gov ↗ ← All trials in Taiwan